February 2017

Europe

Widen the Therapeutic Index of Your ADC Program

World ADC Berlin is Europe’s definitive industry forum for accelerating the development of more therapeutically effective antibody-drug conjugates.

Covering the A-Z of ADCs from early discovery to manufacturing World ADC Berlin gives you an incomparable amount of cutting-edge ADC insights, new data and experiences learned from the last 12 months of drug development.

Annually, over 300 drug developers across 140+ key organisations connect the conference catch up with peers, build new business relationships and further cement partnerships.

This year, the forum served up 45 talks distilling the latest research and novel data on; payloads with different mechanisms of action, validating novel linker technologies; minimising off target toxicities and establishing robust manufacturing supply chains.

With novel ADCs entering the clinic on a monthly basis, rapidly diversifying payload, linker and antibody technologies and a surge of novel preclinical ADCs powering towards the clinic. There will be enormous amounts to share in 2017!

We are already busy building next year’s program . If you are interested in partnering, speaking or attending World ADC Europe simply register your interest and we’ll be in touch.

 

“World ADC allows me to learn how others are innovating in the ADC field, which is simultaneously a humbling experience and a unique opportunity to expand on my own crazy ideas.”
Genentech

“Attending the ADC summit 2016 in Berlin has proved to be a highly useful tool in deciphering the latest trends in the field from all aspects of ADC development and manufacture. This conference is a must for anyone currently working within the ADC arena or looking to move into this exciting field.”
ADC Biotechnology

“Very interesting and informative conference, which covers most of the specific aspects of ADC discovery and development, with many high quality speakers”
Clean Cells



San Diego Infographic